In contrast, for NPM1-mutated AML, which accounts for approximately one-third of AML cases, FTO is aberrantly overexpressed and serves as a carcinogen by promoting the cell cycle and inhibiting apoptosis 67. Here, FTO is linked to acute myeloid leukemia.